Tag: PAT growth
Orchid Pharma posts 169% year-on-year PAT growth in Q1 FY 2024-25
Strategic initiatives and strong market presence propel continued success in the global pharmaceutical industry
Orchid Pharma’s PAT surges by 71.60% in Q4
Innovative drug Enmetazobactam gains EMA & USFDA approval, Orchid Pharma expands presence in the antibiotics market